Temasek Holdings (Private) LTD Bio N Tech Se Transaction History
Temasek Holdings (Private) LTD
- $20.3 Billion
- Q2 2025
A detailed history of Temasek Holdings (Private) LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,506,027 shares of BNTX stock, worth $167 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
1,506,027
Previous 1,807,232
16.67%
Holding current value
$167 Million
Previous $165 Million
2.56%
% of portfolio
0.79%
Previous 0.84%
Shares
9 transactions
Others Institutions Holding BNTX
# of Institutions
318Shares Held
40.9MCall Options Held
1.38MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$399 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...